Buil, Jochem B. http://orcid.org/0000-0003-4031-0778
Schouten, Jeroen A. http://orcid.org/0000-0001-9118-4420
Wauters, Joost http://orcid.org/0000-0002-5983-3897
van de Hoeven, Hans http://orcid.org/0000-0001-7185-8045
Verweij, Paul E. http://orcid.org/0000-0002-8600-9860
,
Article History
Accepted: 16 February 2022
First Online: 22 March 2022
Declarations
:
: JBB reported grants from Gilead Sciences and F2G. JAS has received unrestricted educational and resarch grants from MSD and has been an advisor to Pfizer. JW reported grants from Gilead Sciences, MSD and Pfizer, and non-financial support from Gilead Sciences, Pfizer and MSD. PEV reported grants from Gilead Sciences, MSD, Pfizer and F2G, and non-financial support from OLM and IMMY. All reported grants were outside the submitted work.
Free to read: This content has been made available to all.